Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

CREATINE KINASE ISOENZYMES (CKMB, CKBB, CKMM) - ANVISA Registration 80537410114

Access comprehensive regulatory information for CREATINE KINASE ISOENZYMES (CKMB, CKBB, CKMM) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80537410114 and manufactured by CELER BIOTECNOLOGIA S/A. The registration is held by CELER BIOTECNOLOGIA S/A with validity until May 15, 2033.

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, SIEMENS HEALTHCARE DIAGNOSTICS INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80537410114
Registration Details
ANVISA Registration Number: 80537410114
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

FINECARE CK-MB TESTE RรPIDO QUANTITATIVO
Risk Class III

Registration Details

80537410114

25351326888202272

04846613000103

Company Information

Brazil
PT: BRASIL

Dates and Status

May 15, 2023

15/05/2033

09/18/2025 19:00:01